884 related articles for article (PubMed ID: 23300133)
1. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.
Chiu CT; Wang Z; Hunsberger JG; Chuang DM
Pharmacol Rev; 2013 Jan; 65(1):105-42. PubMed ID: 23300133
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.
Wang ZF; Fessler EB; Chuang DM
Acta Pharmacol Sin; 2011 Dec; 32(12):1433-45. PubMed ID: 22056617
[TBL] [Abstract][Full Text] [Related]
3. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness.
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 2000 Oct; 48(8):740-54. PubMed ID: 11063971
[TBL] [Abstract][Full Text] [Related]
4. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
Linares GR; Chiu CT; Scheuing L; Leng Y; Liao HM; Maric D; Chuang DM
Exp Neurol; 2016 Jul; 281():81-92. PubMed ID: 27085395
[TBL] [Abstract][Full Text] [Related]
6. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.
Missio G; Moreno DH; Demetrio FN; Soeiro-de-Souza MG; Dos Santos Fernandes F; Barros VB; Moreno RA
Trials; 2019 Oct; 20(1):608. PubMed ID: 31655626
[TBL] [Abstract][Full Text] [Related]
8. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
9. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
10. Lithium in bipolar mood disorder.
Dinan TG
BMJ; 2002 Apr; 324(7344):989-90. PubMed ID: 11976227
[No Abstract] [Full Text] [Related]
11. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
12. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
[TBL] [Abstract][Full Text] [Related]
13. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic action of lithium and valproate.
Bielecka AM; Obuchowicz E
Pharmacol Rep; 2008; 60(6):771-82. PubMed ID: 19211968
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?
Scheuing L; Chiu CT; Liao HM; Linares GR; Chuang DM
Int J Biol Sci; 2014; 10(9):1024-38. PubMed ID: 25285035
[TBL] [Abstract][Full Text] [Related]
16. Search for a common mechanism of mood stabilizers.
Harwood AJ; Agam G
Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
[TBL] [Abstract][Full Text] [Related]
17. Lithium and Valproic Acid in Bipolar Disorders and Beyond.
Scarselli M
Curr Neuropharmacol; 2023; 21(4):890. PubMed ID: 37203193
[No Abstract] [Full Text] [Related]
18. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
19. Lithium and valproic acid: parallels and contrasts in diverse signaling contexts.
Gurvich N; Klein PS
Pharmacol Ther; 2002 Oct; 96(1):45-66. PubMed ID: 12441177
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic evidence for manic episode].
Terao T
Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
